Mushroom Gummies and Medications: What the Safety Research Actually Shows

The question of whether functional mushroom supplements interact with medications or have contraindications doesn’t get answered clearly in most supplement marketing. Brands either ignore the question or bury it in a disclaimer that says “consult your doctor” without giving you anything useful to bring to that conversation.

This guide covers the known safety data for the primary functional mushroom species used in daily supplements — including what the published literature has documented about interactions, contraindications, and populations who should exercise caution. It’s written to help you have a more informed conversation with your healthcare provider, not to replace that conversation.

Important: Nothing in this article constitutes medical advice. If you take any prescription medications or have any existing health conditions, consult your healthcare provider before starting any new supplement. This guide covers ingredients as studied in published literature, not specific commercial products.

The General Safety Profile of Functional Mushrooms

The commonly used functional mushroom species — lion’s mane, reishi, cordyceps, chaga, turkey tail, maitake, and shiitake — have long histories of food and traditional medicine use, and the published safety literature is generally reassuring for healthy adults taking them within typical supplement dose ranges.*

Clinical trials on these species have not reported serious adverse events at typical supplemental doses in otherwise healthy populations. The most commonly reported side effects in the published literature are mild gastrointestinal effects — occasional nausea, loose stools, or digestive discomfort — particularly with higher doses or when taken on an empty stomach.* These effects appear to be more common with raw mushroom powder than with hot water extracts, which may be due to the chitin content in unprocessed powder.*

Allergic reactions are possible with any mushroom species, particularly for individuals with known fungal sensitivities. If you have a documented allergy to mushrooms or mold, discuss any functional mushroom supplement with your healthcare provider before starting.*

Lion’s Mane: What the Safety Literature Shows

Lion’s mane (Hericium erinaceus) has a favorable safety profile in published research. Human clinical trials using doses from 500mg to 3,000mg of fruiting body extract daily for periods of up to four months have not reported serious adverse events in healthy adults.*

One area that has received attention in case literature is a potential interaction with antithrombotic or anticoagulant medications. Animal and in vitro research has found that lion’s mane may have some antiplatelet activity. While human data confirming this interaction is limited, individuals taking blood thinners such as warfarin, aspirin, or newer anticoagulants should discuss lion’s mane supplementation with their healthcare provider, who can monitor accordingly.*

One published case report documented an individual with known mushroom allergies who experienced respiratory symptoms after beginning lion’s mane supplementation. This case underscores the importance of fungal allergy history as a factor to discuss with a provider.*

Reishi: Considerations for Longer-Term Use

Reishi (Ganoderma lucidum) has a long history of use in traditional Asian medicine systems, and the modern supplement safety literature reflects a generally well-tolerated compound at standard doses.*

Published safety data has noted a few areas requiring attention for specific populations. Reishi appears to have antiplatelet and mild anticoagulant properties based on in vitro and some animal studies. This is consistent with other functional mushrooms and carries the same caution for individuals on anticoagulant therapy.*

Reishi also appears to have some immunomodulatory effects, which is one of the reasons it’s used for immune support. This same activity is a reason for caution in individuals on immunosuppressive medications — for example, organ transplant recipients or people being treated for autoimmune conditions with immunosuppressants. If you take immunosuppressive drugs, discuss reishi supplementation with your prescribing physician.*

Some published case reports have documented liver function changes in individuals taking very high doses of reishi powder for extended periods. These reports involve doses substantially higher than typical supplement servings, but they establish that long-term high-dose reishi is not without hepatic consideration. Standard supplement servings in the ranges typically studied have not produced these findings.*

Cordyceps: Relevant Considerations for Athletes and Diabetics

Cordyceps (Cordyceps militaris, or Cordyceps sinensis in traditional preparations) has an excellent safety profile in published research at supplemental doses. Clinical trials examining athletic performance and oxygen utilization parameters have not documented significant adverse events in healthy adult populations.*

One area that merits attention is potential blood sugar interaction. Cordyceps has been studied for effects on glucose metabolism, and some research suggests it may have mild hypoglycemic activity. For individuals managing type 2 diabetes with medication, this potential interaction is worth discussing with a healthcare provider, particularly if glucose monitoring shows unexpected changes after beginning supplementation.*

Cordyceps has also shown potential immunostimulatory activity in preclinical studies. As with reishi, this is a consideration for individuals on immunosuppressive therapy.*

Chaga: The Oxalate Consideration

Chaga (Inonotus obliquus) is where there’s a specific, well-documented safety consideration that doesn’t apply to the other primary functional mushroom species: oxalate content.

Chaga mushrooms naturally contain high levels of oxalates — significantly higher than most other functional mushrooms or common dietary sources. Oxalates are compounds that can contribute to kidney stone formation, particularly calcium oxalate stones, which are the most common type of kidney stone. A case report published in 2020 documented acute oxalate nephropathy — a serious kidney condition — in a patient who had been consuming high amounts of chaga mushroom powder daily for multiple months.*

This is a meaningful consideration for individuals with a history of kidney stones, kidney disease, or any condition affecting kidney function. The chaga doses implicated in the published case were substantially higher than typical supplement servings, but the biochemical mechanism is dose-dependent, and individuals with kidney concerns should discuss chaga-containing supplements with their healthcare provider.*

For healthy individuals without kidney stone history or kidney disease, chaga at typical supplement doses has not been associated with adverse events in published literature. The oxalate risk is worth knowing and disclosing to your provider; it is not a universal contraindication for all users.*

Turkey Tail, Maitake, and Shiitake: Summary Safety Notes

Turkey tail (Trametes versicolor) is among the better-studied functional mushrooms, partly because its active compounds PSK and PSP have been researched in oncology contexts. Safety data from those trials — which used much higher doses than typical supplementation — has been generally favorable for healthy adults. Turkey tail does carry the same general immunomodulatory consideration as reishi and cordyceps for individuals on immunosuppressive medications.*

Maitake (Grifola frondosa) has a favorable general safety profile. Similar to cordyceps, it has been studied in the context of blood sugar regulation, which creates a mild consideration for individuals managing diabetes with medication.*

Shiitake (Lentinula edodes) is widely consumed as a food and has a well-established safety record. A phenomenon called shiitake dermatitis — a flagellate-pattern skin rash — has been documented in association with consumption of raw or undercooked shiitake, but it has not been noted in connection with the hot water extracts used in functional mushroom supplements.*

What to Tell Your Healthcare Provider

When you discuss a functional mushroom supplement with your healthcare provider, the most relevant information to bring is the specific species list, the extract form, and the dose. Bringing the product label is more useful than a general conversation about “mushroom supplements.”

The most relevant interaction categories to discuss, based on the literature reviewed above:

Anticoagulant or antiplatelet medications (warfarin, aspirin therapy, newer blood thinners): lion’s mane and reishi both have preliminary evidence of antiplatelet activity. This doesn’t mean the interaction is confirmed or clinically significant at supplement doses, but it warrants monitoring.*

Immunosuppressive medications: reishi, cordyceps, and turkey tail all have immunomodulatory research. If you take immunosuppressants, the interaction is worth discussing.*

Diabetes medications: cordyceps and maitake have been studied for glucose metabolism effects. Discuss with the provider managing your diabetes care.*

Kidney disease or kidney stone history: chaga’s oxalate content is the relevant consideration here.*

Fungal allergies: any mushroom-based supplement should be discussed with a provider who knows your allergy history.*

Applying This to a Multi-Mushroom Product Like Auri Daily Gummies

A 12-species blend like the Auri Super Mushroom Daily Gummies contains several of the species discussed above — lion’s mane, reishi, cordyceps, chaga, turkey tail, maitake, and shiitake among them. The safety considerations described in this guide apply to those species regardless of which product they appear in.*

The 300mg total serving at a 10:1 extract ratio represents a relatively low dose per species compared to the doses used in the published safety and efficacy literature. Lower doses are generally associated with lower risk, but this doesn’t eliminate the interaction considerations above for relevant populations.*

For the full formulation evaluation of the Auri Daily Gummies, see our anchor review. For species-specific research on any of the species covered in this guide, the Top Shelf Mushrooms library provides detailed species profiles with full source citations.

*All research referenced relates to species as studied in published scientific literature. Individual outcomes vary. This guide is for educational purposes and is not a substitute for advice from your healthcare provider.

Top Shelf Mushrooms is an independent editorial publication covering functional mushroom research and education. Nothing on this site constitutes medical advice. Always consult a qualified healthcare provider before beginning any supplement, particularly if you take medications or have existing health conditions. See our Research Standards & Disclosure for full details.